SIEMENS UK & IRELAND APPOINTS NEW HEAD OF PHARMACEUTICAL & LIFE SCIENCES SECTOR
16/03/2016 Siemens plc
Siemens UK & Ireland has appointed Alwyn Jones (pictured) as its new Vertical Sector Head for Pharmaceutical & Life Sciences, to deliver its business strategy for the sector.Alwyn is joining the Pharmaceutical team following four years as an Account Development Manager for the Environmental Power sector, where he helped to secure specification for Siemens UK & Ireland on a number of strategic Energy from Waste projects, working in collaboration with customers and solution partners.
Prior to that, Alwyn worked for a couple of Siemens UK & Ireland's solution partners who primarily serviced the Pharmaceutical and other 'highly regulated' sectors, where he acquired a wealth of experience to equip him for his new role.
Mike Houghton, Managing Director of Process Industries & Drives at Siemens UK & Ireland comments: "This new appointment will strengthen our approach to the UK & Ireland pharmaceuticals market, ensuring we continue to offer the support and solutions our customers in that sector need.
"We have strong sector specialist teams operating across the business and we would like to wish Alwyn every success for the future as he joins these and takes on his new position."
Alwyn Jones said: "I am very much looking forward to working in collaboration with customers from across the Pharmaceutical industry to deliver solutions to help solve key business issues in this sector.
"My background has given me a thorough understanding of the challenges that manufacturers operating within the Pharma industry face, so I plan to apply this knowledge in my new role."
For more information, please contact:
Anne Keogh
Siemens plc
Sir William Siemens Square
Frimley
Camberley
Surrey
GU16 8QD
Tel: +44 1276 696312
Email: anne.keogh@siemens.com
Web: www.siemens.co.uk.
Share article:
Process and Control Today are not responsible for the content of submitted or externally produced articles and images. Click here to email us about any errors or omissions contained within this article.
